Cerus Corp. (NASDAQ:CERS) shares were down 3.7% during trading on Wednesday . The company traded as low as $6.26 and last traded at $6.26, with a volume of 718,939 shares changing hands. The stock had previously closed at $6.50.

A number of research analysts have recently commented on CERS shares. Robert W. Baird reiterated an “outperform” rating and issued a $9.00 price target on shares of Cerus Corp. in a research note on Wednesday, March 16th. FBR & Co reiterated an “outperform” rating and issued a $10.00 price target on shares of Cerus Corp. in a research note on Wednesday, March 16th. BTIG Research reiterated a “buy” rating and issued a $10.00 price target (up from $8.00) on shares of Cerus Corp. in a research note on Friday, April 22nd. Finally, Cantor Fitzgerald reiterated a “buy” rating and issued a $9.00 price target on shares of Cerus Corp. in a research note on Thursday, July 7th. Two analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $8.90.

The company’s market capitalization is $636.70 million. The firm’s 50 day moving average price is $6.01 and its 200-day moving average price is $5.81.

Cerus Corp. (NASDAQ:CERS) last announced its quarterly earnings data on Tuesday, May 3rd. The company reported ($0.17) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.16) by $0.01. During the same quarter in the previous year, the business posted ($0.17) EPS. The business had revenue of $7.60 million for the quarter, compared to analyst estimates of $8.29 million. The business’s revenue for the quarter was down 1.3% on a year-over-year basis. Analysts anticipate that Cerus Corp. will post ($0.65) EPS for the current fiscal year.

A number of large investors have made changes to their positions in CERS. California State Teachers Retirement System boosted its stake in shares of Cerus Corp. by 1.8% in the fourth quarter. California State Teachers Retirement System now owns 176,709 shares of the company’s stock worth $1,117,000 after buying an additional 3,126 shares during the period. Stephens Inc. AR boosted its stake in shares of Cerus Corp. by 11.3% in the fourth quarter. Stephens Inc. AR now owns 1,112,665 shares of the company’s stock worth $7,032,000 after buying an additional 113,238 shares during the period. Rail Splitter Capital Management LLC boosted its stake in shares of Cerus Corp. by 19.0% in the fourth quarter. Rail Splitter Capital Management LLC now owns 832,722 shares of the company’s stock worth $5,263,000 after buying an additional 132,970 shares during the period. EAM Investors LLC acquired a new stake in shares of Cerus Corp. during the fourth quarter worth $1,139,000. Finally, Wells Fargo & Company MN boosted its stake in shares of Cerus Corp. by 25.9% in the fourth quarter. Wells Fargo & Company MN now owns 4,901,666 shares of the company’s stock worth $30,979,000 after buying an additional 1,007,430 shares during the period.

Cerus Corporation is a biomedical products company. The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety. The Company operates through blood safety segment. The Company’s INTERCEPT Blood System is based on its technology for controlling biological replication, and is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.